Leverage our team's decades of experience in the field to develop a strategic plan for value creation through M&A. Whether through a roll-up, vertical integration, product development or channel expansion, our team can drive the development of a strategy for success.
Deep industry relationships and a full understanding of the players allows our team to quickly identify the right M&A opportunities for your investment strategy.
Whether its early-stage technology, or new intellectual property, our team has both the clinical expertise and technical skills to analyze and provide useful insights to help make the right decisions.
Our team has years of experience in running operations both large and small, with expertise in drugs, medical devices, cosmetics and food. With skills in automation, lean manufacturing, supply chain optimization, information technology and talent management, our team can provide assessments on virtually every aspect of an operation.
With over three dozen acquisitions under our belts, we understand the importance of proper diligence and its role in the investment process. The Mill Street Equity team members have each personally led or played significant roles in due diligence ranging from customer analysis, product evaluation, legal, intellectual property, finance, HR, and regulatory.
We work side by side with financial sponsors to negotiate the best terms possible during M&A and/or licensing transactions. Whether on the buy side or the sell side, our industry knowledge can ensure substantial value.
Each member of the Mill Street Equity team has held a C-level and/or Chairman position with multiple Board appointments in both public and privately held companies. The team is available to provide hands-on leadership.
Mill Street Equity
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.